Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab

Wang, LZ; Zhang, Y; He, YJ; Li, JF; Wang, TF; Xie, YT; Fan, ZQ; Ouyang, T

Fan, ZQ; Ouyang, T (corresponding author), Peking Univ Canc Hosp & Inst, Breast Canc Ctr, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China.

NPJ BREAST CANCER, 2021; 7 (1):

Abstract

To compare outcomes in patients with human epidermal growth factor receptor-2 (HER2)-positive breast cancer who received either dose-dense neoadjuvant......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索